MET and non-small cell lung carcinoma: To investigate if TWIST1 was induced at the time of MET TKIs resistance, we first generated a novel capmatinib resistant PDX from a previously characterized PDX (UW-21-lung) [28] from a patient with a MET exon 14 mutant NSCLC brain metastasis.